Global Erythropoietin (EPO) Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)
Segmented by Drug Class;
Biologics and Biosimilars.Segmented by Product;
Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Others.Segmented by Application;
Cancer, Hematology, Renal Diseases and Neurology.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).Introduction
Global Erythropoietin (EPO) Drugs Market (USD Million), 2018 - 2028
# | Global |
---|---|
2018 | 81.3 |
2019 | 86.6 |
2020 | 92.0 |
2021 | 105.9 |
2022 | 109.7 |
2023 | 126.4 |
2024 | 145.4 |
2025 | 153.8 |
2026 | 163.9 |
2027 | 167.4 |
2028 | 182.6 |
In the year 2021, the Global Erythropoietin (EPO) Drugs Market was valued at USD 9,527.15 million. The size of this market is expected to increase to USD 13,969.66 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 5.6%.
Global Erythropoietin (EPO) Drugs Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Erythropoietin (EPO) Drugs Market |
Study Period | 2018 - 2028 |
Base Year (for Erythropoietin (EPO) Drugs Market Size Estimates) | 2021 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Erythropoietin (EPO) Drugs Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Erythropoietin (EPO) Drugs Market Analysis
In this report, the Global Erythropoietin (EPO) Drugs Market has been segmented by Drug Class, Product, Application and Geography.
Global Erythropoietin (EPO) Drugs Market , Segmentation by Drug Class
The Global Erythropoietin (EPO) Drugs Market has been segmented by Drug Class into Biologics and Biosimilars. The complete Global Erythropoietin (EPO) Drugs Market segmentation by Drug Class can be seen below:
- Global Erythropoietin (EPO) Drugs Market, By Drug Class
- Biologics
- Biosimilars
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Classs mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Class is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Erythropoietin (EPO) Drugs Market , by Drug Class (USD Million), 2018 - 2028
# | Biologics | Biosimilars |
---|---|---|
2018 | 67.7 | 90.5 |
2019 | 70.7 | 103.9 |
2020 | 74.4 | 120.0 |
2021 | 84.5 | 125.8 |
2022 | 86.0 | 129.1 |
2023 | 86.2 | 141.6 |
2024 | 88.7 | 146.0 |
2025 | 94.3 | 157.7 |
2026 | 95.2 | 158.6 |
2027 | 98.5 | 170.5 |
2028 | 104.4 | 171.7 |
Global Erythropoietin (EPO) Drugs Market , Segmentation by Product
The Global Erythropoietin (EPO) Drugs Market has been segmented by Product into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Others. The complete Global Erythropoietin (EPO) Drugs Market segmentation by Product can be seen below:
- Global Erythropoietin (EPO) Drugs Market, By Product
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Products mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Erythropoietin (EPO) Drugs Market , by Product (USD Million), 2018 - 2028
# | Epoetin-alfa | Epoetin-beta | Darbepoetin-alfa | Others |
---|---|---|---|---|
2018 | 81.9 | 73.4 | 74.2 | 80.6 |
2019 | 88.2 | 83.8 | 81.8 | 83.2 |
2020 | 89.6 | 93.5 | 87.8 | 92.0 |
2021 | 89.9 | 98.6 | 102.1 | 102.4 |
2022 | 91.0 | 111.1 | 121.4 | 107.4 |
2023 | 92.1 | 126.9 | 144.3 | 117.8 |
2024 | 101.8 | 128.5 | 148.3 | 132.0 |
2025 | 110.8 | 143.6 | 153.5 | 133.6 |
2026 | 120.7 | 155.3 | 158.1 | 138.2 |
2027 | 139.0 | 174.6 | 164.4 | 141.4 |
2028 | 163.4 | 200.7 | 174.9 | 161.8 |
Global Erythropoietin (EPO) Drugs Market , Segmentation by Application
The Global Erythropoietin (EPO) Drugs Market has been segmented by Application into Cancer, Hematology, Renal Diseases and Neurology. The complete Global Erythropoietin (EPO) Drugs Market segmentation by Application can be seen below:
- Global Erythropoietin (EPO) Drugs Market, By Application
- Cancer
- Hematology
- Renal Diseases
- Neurology
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Applications mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Application is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Erythropoietin (EPO) Drugs Market , by Application (USD Million), 2018 - 2028
# | Cancer | Hematology | Renal Diseases | Neurology |
---|---|---|---|---|
2018 | 76.5 | 64.5 | 76.2 | 82.3 |
2019 | 86.0 | 67.7 | 76.8 | 86.5 |
2020 | 99.3 | 74.8 | 89.5 | 101.0 |
2021 | 100.1 | 74.9 | 92.5 | 101.3 |
2022 | 110.8 | 81.4 | 106.0 | 113.7 |
2023 | 112.2 | 92.0 | 125.3 | 118.1 |
2024 | 122.8 | 102.9 | 129.0 | 134.0 |
2025 | 139.4 | 119.8 | 149.0 | 153.9 |
2026 | 163.8 | 139.2 | 149.6 | 180.5 |
2027 | 193.0 | 142.6 | 151.8 | 202.6 |
2028 | 210.5 | 170.2 | 181.1 | 215.2 |
Global Erythropoietin (EPO) Drugs Market, Segmentation by Geography
In this report, the Global Erythropoietin (EPO) Drugs Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Erythropoietin (EPO) drug used to boost red blood cell counts in a practice called "blood doping"—falls under the same umbrella of forbidden substances. In fact, EPO has been a source of widespread abuse and controversy among professional cyclists since the 1980s
Global Erythropoietin (EPO) Drugs Market Share (%), by Geographical Region, 2021
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Erythropoietin (EPO) Drugs Market in all the Regions and Countries (specified above) for historic (2018 - 2021) and forecast (2022 - 2028) Periods with 2021 considered as the base year.
This report also provides an analysis of why the market size of Erythropoietin (EPO) Drugs in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Erythropoietin (EPO) Drugs Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Erythropoietin (EPO) Drugs Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Erythropoietin (EPO) Drugs Market will be discussed in detail in the full report.
- The new opportunities in Global Erythropoietin (EPO) Drugs Market will be discussed in detail in the full report.
- Global Erythropoietin (EPO) Drugs Market Drivers will be discussed in detail in the full report.
- Global Erythropoietin (EPO) Drugs Market Restraints will be discussed in detail in the full report.
- Global Erythropoietin (EPO) Drugs Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Erythropoietin (EPO) Drugs Market. The opportunity map (by market segments; Drug Class, Product and Application) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Erythropoietin (EPO) Drugs Market, Opportunity Map, By Region (2018 - 2028)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Erythropoietin (EPO) Drugs Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Erythropoietin (EPO) Drugs Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Erythropoietin (EPO) Drugs Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Buy Erythropoietin (EPO) because it assists erythropoiesis, a process of production of red blood cells in the bone marrow. In turn, red blood cells enhance the oxygen-carrying capacity of human blood. 10mU/mL is the amount of erythropoietin secreted by kidneys to compensate for RBC turnover. Erythropoietin Products. Erythropoietin/EPO is a renal glycoprotein hormone that promotes erythrocyte formation by preventing the apoptosis of early erythroid precursors which express the EPO receptor (EPO R). Rapid regulation of circulating EPO allows tight control of erythrocyte production and hemoglobin concentrations. An epo competitor monitoring patent portfolio. However, anyone who has tracked a patent through the USPTO's Public PAIR website or the EPO's website knows how time-consuming and tedious the process is to find any new prosecution developments.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Erythropoietin (EPO) Drugs Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Erythropoietin (EPO) Drugs Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Erythropoietin (EPO) Drugs Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Erythropoietin (EPO) Drugs Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Erythropoietin (EPO) Drugs Market include, Johnson & Johnson, Celltrion, Inc., Teva Pharmaceutical Industries Ltd, Amgen, Inc., F. Hoffman-La Roche Ltd., LG Life Sciences Ltd., Biocon Limited, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd. and Dr. Reddys Laboratories Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Region
- Market Opportunity Map
- Global Erythropoietin (EPO) Drugs Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Erythropoietin (EPO) Drugs Market, By Drug Class, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Biologics
- Global Erythropoietin (EPO) Drugs Market, By Product, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Epoetin-alfa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Epoetin-beta
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Darbepoetin-alfa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Epoetin-alfa
- Global Erythropoietin (EPO) Drugs Market, By Application, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Renal Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Cancer
- Global Erythropoietin (EPO) Drugs Market, By Geography, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2028 (USD Million)
- Brazil
- North America
- Global Erythropoietin (EPO) Drugs Market, By Drug Class, 2018 - 2028 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Johnson & Johnson
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Celltrion, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Teva Pharmaceutical Industries Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Amgen, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffman-La Roche Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- LG Life Sciences Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Biocon Limited
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Intas Pharmaceuticals Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Sun Pharmaceutical Industries Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Dr. Reddy’s Laboratories Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Johnson & Johnson
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2021, the Global Excipients Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Exoskeleton Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Exosomes Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%